潍坊医学院学报
濰坊醫學院學報
유방의학원학보
JOURNAL OF WEIFANG MEDICAL COLLEGE
2014年
2期
81-83
,共3页
陈星星%曾惠阳%刘谦%卢清君%唐胜建
陳星星%曾惠暘%劉謙%盧清君%唐勝建
진성성%증혜양%류겸%로청군%당성건
视网膜变性%CC趋化因子拮抗剂%Met-RANTES%rd小鼠/自发性遗传性视网膜变性
視網膜變性%CC趨化因子拮抗劑%Met-RANTES%rd小鼠/自髮性遺傳性視網膜變性
시망막변성%CC추화인자길항제%Met-RANTES%rd소서/자발성유전성시망막변성
Retinal degeneration%Chemokine antagonist%Met-RANTES
目的:研究CC趋化因子拮抗剂Met-RANTES对rd小鼠视网膜外核层形态的影响,探讨其在rd小鼠遗传性视网膜变性中的潜在治疗作用。方法以出生后7drd小鼠作为研究对象,随机分为5组,分别给予腹腔注射Met-RANTES、PBS和玻璃体腔注射不同浓度Met-RANTES、PBS,直到rd小鼠出生后14d,过量麻醉法处死后摘取眼球制作冰冻切片,HE染色后观察测量视网膜后极部外核层厚度。结果腹腔注射met-RANTES、玻璃体腔注射0.7μlMet-RANTESrd小鼠与对照小鼠视网膜外核层细胞层数无明显变化(P>0.05)。玻璃体腔注射1.0μlMet-RANTES和1.5μlMet-RANTES眼球视网膜外核层比对照眼球视网膜外核层厚,有统计学差异(P<0.05)。结论CC趋化因子拮抗剂Met-RANTES对rd小鼠遗传性视网膜变性可能存有潜在治疗作用。
目的:研究CC趨化因子拮抗劑Met-RANTES對rd小鼠視網膜外覈層形態的影響,探討其在rd小鼠遺傳性視網膜變性中的潛在治療作用。方法以齣生後7drd小鼠作為研究對象,隨機分為5組,分彆給予腹腔註射Met-RANTES、PBS和玻璃體腔註射不同濃度Met-RANTES、PBS,直到rd小鼠齣生後14d,過量痳醉法處死後摘取眼毬製作冰凍切片,HE染色後觀察測量視網膜後極部外覈層厚度。結果腹腔註射met-RANTES、玻璃體腔註射0.7μlMet-RANTESrd小鼠與對照小鼠視網膜外覈層細胞層數無明顯變化(P>0.05)。玻璃體腔註射1.0μlMet-RANTES和1.5μlMet-RANTES眼毬視網膜外覈層比對照眼毬視網膜外覈層厚,有統計學差異(P<0.05)。結論CC趨化因子拮抗劑Met-RANTES對rd小鼠遺傳性視網膜變性可能存有潛在治療作用。
목적:연구CC추화인자길항제Met-RANTES대rd소서시망막외핵층형태적영향,탐토기재rd소서유전성시망막변성중적잠재치료작용。방법이출생후7drd소서작위연구대상,수궤분위5조,분별급여복강주사Met-RANTES、PBS화파리체강주사불동농도Met-RANTES、PBS,직도rd소서출생후14d,과량마취법처사후적취안구제작빙동절편,HE염색후관찰측량시망막후겁부외핵층후도。결과복강주사met-RANTES、파리체강주사0.7μlMet-RANTESrd소서여대조소서시망막외핵층세포층수무명현변화(P>0.05)。파리체강주사1.0μlMet-RANTES화1.5μlMet-RANTES안구시망막외핵층비대조안구시망막외핵층후,유통계학차이(P<0.05)。결론CC추화인자길항제Met-RANTES대rd소서유전성시망막변성가능존유잠재치료작용。
Objective To study the effect of chemokine antagonist Met-RANTES on outer nuclear layer reti-na in the retinal degenerative process in rd mice and further explore its role in the photoreceptor degeneration .Methods Rd mice at postnatal day ( P) 7 were enrolled and divided to 5 groups.The subjects were treated with intraperitoneal injection or intravitreous injection with Met-RANTES,PBS in different concentrations .The mice were sacrificed and reti-nal sections were prepared ,which were stained by hematoxylin-eosin staining ( HE) .Then the thickness of outer nuclear layer retinas were detected the thickness of outer nuclear layer retina respectively .The use and care of the animals com-plied with the guideline of ARVO .Results There was no evident diffiernce between the rd mice which were treated by Met-RANTES and their control group(P>0.05).So did the rd mice which were treated by 0.7μl Met-RANTES with glass body cavity injection .However,the rd mice which treated by 1.0μl or 1.5μl Met-RANTES were obviously thicker than their control retinas ( P<0 .05 ) .Conclusion Chemokine antagonist Met-RANTES may poly a therapeutic role in the retinal degenerative process in rd mice .